BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA. Milk thistle for the treatment of liver disease. The American Journal of Medicine 2002;113:506-15. [DOI: 10.1016/s0002-9343(02)01244-5] [Cited by in Crossref: 154] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Yaghmaei P, Azarfar K, Dezfulian M, Ebrahim-Habibi A. Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model. Daru 2014;22:24. [PMID: 24460990 DOI: 10.1186/2008-2231-22-24] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
2 El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasit Vectors 2012;5:9. [PMID: 22236605 DOI: 10.1186/1756-3305-5-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
3 Mudge E, Paley L, Schieber A, Brown PN. Optimization and single-laboratory validation of a method for the determination of flavonolignans in milk thistle seeds by high-performance liquid chromatography with ultraviolet detection. Anal Bioanal Chem 2015;407:7657-66. [PMID: 26229030 DOI: 10.1007/s00216-015-8925-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
4 El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine. 2009;16:391-400. [PMID: 19303273 DOI: 10.1016/j.phymed.2009.02.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
5 de Oliveira DR, Tintino SR, Braga MF, Boligon AA, Athayde ML, Coutinho HD, de Menezes IR, Fachinetto R. In vitro antimicrobial and modulatory activity of the natural products silymarin and silibinin. Biomed Res Int 2015;2015:292797. [PMID: 25866771 DOI: 10.1155/2015/292797] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
6 Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials. Am J Gastroenterol 2005;100:2583-91. [PMID: 16279916 DOI: 10.1111/j.1572-0241.2005.00262.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
7 Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci. 2005;50:1807-1812. [PMID: 16187178 DOI: 10.1007/s10620-005-2942-9] [Cited by in Crossref: 116] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
8 Voroneanu L, Nistor I, Dumea R, Apetrii M, Covic A. Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Diabetes Res 2016;2016:5147468. [PMID: 27340676 DOI: 10.1155/2016/5147468] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
9 Polyak SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, Graf TN, Oberlies NH. Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci USA. 2010;107:5995-5999. [PMID: 20231449 DOI: 10.1073/pnas.0914009107] [Cited by in Crossref: 177] [Cited by in F6Publishing: 163] [Article Influence: 14.8] [Reference Citation Analysis]
10 Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009; 15(16): 1943-1950 [PMID: 19399925 DOI: 10.3748/wjg.15.1943] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
11 Chiu HW, Hua KF. Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat. PLoS One 2016;11:e0153087. [PMID: 27046059 DOI: 10.1371/journal.pone.0153087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mohammadi SM, kianbakht S, Rezazadeh S, Ziaee M, Fallah Huseini H; Department of Internal Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review. J Med Plants 2020;1:12-26. [DOI: 10.29252/jmp.1.73.12] [Reference Citation Analysis]
14 Anderson TR, Slotkin TA. Maturation of the adrenal medulla--IV. Effects of morphine. Biochem Pharmacol 1975;24:1469-74. [PMID: 7 DOI: 10.1016/0006-2952(75)90020-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.5] [Reference Citation Analysis]
15 Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y, Sloan DD, Graf TN, Oberlies NH, Lee DY. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology. 2010;138:671-681, 681.e1-2. [PMID: 19782083 DOI: 10.1053/j.gastro.2009.09.021] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 5.7] [Reference Citation Analysis]
16 Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012; 4(3): 81-90 [PMID: 22489260 DOI: 10.4254/wjh.v4.i3.81] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 10.1] [Reference Citation Analysis]
17 Wang R, Kong J, Wang D, Lien LL, Lien EJ. A survey of Chinese herbal ingredients with liver protection activities. Chin Med. 2007;2:5. [PMID: 17490493 DOI: 10.1186/1749-8546-2-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
18 Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond) 2013;13:7-12. [PMID: 23472485 DOI: 10.7861/clinmedicine.13-1-7] [Cited by in Crossref: 107] [Cited by in F6Publishing: 74] [Article Influence: 11.9] [Reference Citation Analysis]
19 Lama S, Vanacore D, Diano N, Nicolucci C, Errico S, Dallio M, Federico A, Loguercio C, Stiuso P. Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures. Sci Rep 2019;9:3228. [PMID: 30824780 DOI: 10.1038/s41598-019-40105-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
20 Schatz G, Kumala E, Nathwani A. A Collaborative Integrative and Ayurvedic Approach to Cirrhosis in the setting of Autoantibody Negative Autoimmune Hepatitis. Advances in Integrative Medicine 2021. [DOI: 10.1016/j.aimed.2021.10.002] [Reference Citation Analysis]
21 Li Y, Ye Z, Lai W, Rao J, Huang W, Zhang X, Yao Z, Lou T. Activation of Sirtuin 3 by Silybin Attenuates Mitochondrial Dysfunction in Cisplatin-induced Acute Kidney Injury. Front Pharmacol 2017;8:178. [PMID: 28424621 DOI: 10.3389/fphar.2017.00178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
22 Yang Z, Zhuang L, Lu Y, Xu Q, Chen X. Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2014;2014:941085. [PMID: 25247194 DOI: 10.1155/2014/941085] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
23 Awwad A, Poucheret P, Idres AY, Bidel L, Tousch D. The bitter Asteraceae: An interesting approach to delay the metabolic syndrome progression. NFS Journal 2020;18:29-38. [DOI: 10.1016/j.nfs.2020.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
24 Zhang S, Morris ME. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm Res 2003;20:1184-91. [PMID: 12948016 DOI: 10.1023/a:1025044913766] [Cited by in Crossref: 87] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
25 Li Y, Martin RC 2nd. Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med 2011;2011:541209. [PMID: 21799681 DOI: 10.1093/ecam/neq044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
26 Lu P, Mamiya T, Lu LL, Mouri A, Zou L, Nagai T, Hiramatsu M, Ikejima T, Nabeshima T. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 2009;157:1270-7. [PMID: 19552690 DOI: 10.1111/j.1476-5381.2009.00295.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 10.1] [Reference Citation Analysis]
27 Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 2010; 16(48): 6035-6043 [PMID: 21182217 DOI: 10.3748/wjg.v16.i48.6035] [Cited by in CrossRef: 139] [Cited by in F6Publishing: 128] [Article Influence: 11.6] [Reference Citation Analysis]
28 Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett 2012;326:88-95. [PMID: 22863537 DOI: 10.1016/j.canlet.2012.07.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
29 Loguercio C, Festi D. Silybin and the liver: From basic research to clinical practice. World J Gastroenterol 2011; 17(18): 2288-2301 [PMID: 21633595 DOI: 10.3748/wjg.v17.i18.2288] [Cited by in CrossRef: 200] [Cited by in F6Publishing: 170] [Article Influence: 18.2] [Reference Citation Analysis]
30 Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food. 2013;16:778-784. [PMID: 23909904 DOI: 10.1089/jmf.2012.2534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
31 Kemelo MK, Kutinová Canová N, Horinek A, Farghali H. Sirtuin-Activating Compounds (STACs) Alleviate D-Galactosamine/Lipopolysaccharide-Induced Hepatotoxicity in Rats: Involvement of Sirtuin 1 and Heme Oxygenase 1. Physiol Res. [DOI: 10.33549/physiolres.933488] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
32 Senturk H, Kabay S, Bayramoglu G, Ozden H, Yaylak F, Yucel M, Olgun EG, Kutlu A. Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney. World J Urol 2008;26:401-7. [PMID: 18408933 DOI: 10.1007/s00345-008-0256-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
33 Meddeb W, Rezig L, Abderrabba M, Lizard G, Mejri M. Tunisian Milk Thistle: An Investigation of the Chemical Composition and the Characterization of Its Cold-Pressed Seed Oils. Int J Mol Sci 2017;18:E2582. [PMID: 29207484 DOI: 10.3390/ijms18122582] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
34 Cheng KC, Asakawa A, Li YX, Chung HH, Amitani H, Ueki T, Cheng JT, Inui A. Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats. PLoS One 2014;9:e84550. [PMID: 24404172 DOI: 10.1371/journal.pone.0084550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
35 Xu P, Zhou H, Li YZ, Yuan ZW, Liu CX, Liu L, Xie Y. Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2. Front Pharmacol 2018;9:1115. [PMID: 30416442 DOI: 10.3389/fphar.2018.01115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
36 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
37 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Reference Citation Analysis]
38 Cacciapuoti F, Scognamiglio A, Palumbo R, Forte R, Cacciapuoti F. Silymarin in non alcoholic fatty liver disease. World J Hepatol 2013; 5(3): 109-113 [PMID: 23556042 DOI: 10.4254/wjh.v5.i3.109] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
39 Hussain MS. Patient counseling about herbal-drug interactions. Afr J Tradit Complement Altern Med 2011;8:152-63. [PMID: 22754069 DOI: 10.4314/ajtcam.v8i5S.8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
40 Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology 2008;47:605-12. [PMID: 18157835 DOI: 10.1002/hep.22044] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 6.8] [Reference Citation Analysis]
41 de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, de Oliveira LPM. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J Gastroenterol 2017; 23(27): 5004-5017 [PMID: 28785154 DOI: 10.3748/wjg.v23.i27.5004] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
42 Qiu MF, Jia W, Li SS, Xu ZH, Sun X, Wang XR, Zhang YY, Xie GX. A new silymarin preparation based on solid dispersion technique. Adv Ther 2005;22:595-600. [PMID: 16510376 DOI: 10.1007/BF02849953] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
43 Wei F, Liu SK, Liu XY, Li ZJ, Li B, Zhou YL, Zhang HY, Li YW. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B. Eur J Clin Microbiol Infect Dis 2013;32:657-69. [PMID: 23247631 DOI: 10.1007/s10096-012-1789-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
44 Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR; Silymarin in NASH and C Hepatitis (SyNCH) Study Group. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA 2012;308:274-82. [PMID: 22797645 DOI: 10.1001/jama.2012.8265] [Cited by in Crossref: 105] [Cited by in F6Publishing: 84] [Article Influence: 10.5] [Reference Citation Analysis]